Future investigations should aim not only to validate the functional predictions but also to investigate how glycosylation changes in SV2C might contribute to the pathophysiology of PD, potentially unveiling new disease pathways for therapeutic intervention. This evidence concerns the gene SV2C and Parkinson disease.